USPTO Examiner CARPENTER WILLIAM R - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19024865Auto-InjectorJanuary 2025March 2025Allow200YesNo
19025292Auto-InjectorJanuary 2025April 2025Allow300YesNo
18968713SYSTEMS, METHODS, AND DEVICES FOR ADVANCING AN ENDOVASCULAR INSTRUMENTDecember 2024April 2025Allow410YesNo
18824125NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENTSeptember 2024October 2024Allow200YesNo
18622233Auto-InjectorMarch 2024October 2024Allow610YesNo
18622358Auto-InjectorMarch 2024October 2024Allow610YesNo
18622306Auto-InjectorMarch 2024October 2024Allow610YesNo
18599867Auto-InjectorMarch 2024August 2024Allow510YesNo
18412401VASCULATURE NAVIGATION SYSTEMS AND METHODSJanuary 2024September 2024Allow811YesNo
18570293A DRUG INJECTION DEVICE AND RECYCLING SYSTEMDecember 2023July 2024Allow700YesNo
18498416Auto-InjectorOctober 2023April 2025Allow1700YesNo
18225864SYSTEM FOR ANCHORING MEDICAL DEVICESJuly 2023January 2025Allow1700YesNo
18224828MEDICAL PUMPJuly 2023November 2024Allow1601YesNo
18348443Smart Self-Activating Wearable Device for Automatically Injecting MedicinesJuly 2023May 2025Abandon2310NoNo
18324069IRRIGATION AND ASPIRATION DEVICE AND METHODMay 2023September 2023Allow400YesNo
18311072CATHETERS AND RELATED DEVICES AND METHODS OF MANUFACTUREMay 2023September 2024Allow1700YesNo
18305747AUTOMATED COMPRESSION NURSING AND PUMPING SYSTEMApril 2023February 2025Abandon2210NoNo
18134841Needle Actuator Assembly for Drug Delivery SystemApril 2023March 2025Allow2311YesNo
18296292MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSApril 2023December 2023Allow820YesNo
18125810Intravesical Drug Delivery DevicesMarch 2023January 2025Allow2211YesNo
18110223Detachable Needle Syringe Having Reduced Dead SpaceFebruary 2023March 2025Abandon2520NoNo
18063918SYRINGEDecember 2022April 2024Allow1600YesNo
17994961Auto-InjectorNovember 2022February 2023Allow200YesNo
17983243INTRODUCER SHEATHSNovember 2022December 2024Abandon2510NoNo
17952801Auto-InjectorSeptember 2022January 2023Allow410YesNo
17941793BI-DIRECTIONAL PERFUSION CANNULASeptember 2022August 2024Allow2310YesNo
17892042Smart Self-Activating Wearable Device For Automatically Injecting MedicinesAugust 2022April 2023Allow800YesNo
17860601NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENTJuly 2022June 2024Allow2300YesNo
17850236SAFETY PEN NEEDLE ASSEMBLYJune 2022February 2024Abandon2001NoNo
17845521Auto-InjectorJune 2022August 2022Allow200YesNo
17841070PLATE WITH INTEGRAL FLUID PATH CHANNELSJune 2022April 2024Allow2201YesNo
17806681MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSJune 2022December 2022Allow610YesNo
17730313WINGED NEEDLE SET SECUREMENTApril 2022December 2023Allow2010YesNo
17708975DOUBLE BALLOON VASCULAR OCCLUSION CATHETERMarch 2022May 2024Abandon2611NoNo
17706444Auto-InjectorMarch 2022August 2022Allow510YesNo
17706389Auto-InjectorMarch 2022May 2022Allow200YesNo
17675509SYRINGE AND METHOD OF PREPARING SYRINGEFebruary 2022May 2023Allow1500NoNo
17584627CATHETERS AND RELATED DEVICES AND METHODS OF MANUFACTUREJanuary 2022January 2023Allow1121YesNo
17574279SYSTEM AND METHOD FOR MULTIPLE SITE INJECTIONJanuary 2022February 2025Allow3700YesNo
17569143Needle Hub for Drug Delivery DeviceJanuary 2022July 2024Allow3121YesNo
17552376Diabetes Overlay Patch ShieldDecember 2021February 2025Abandon3820NoNo
17553255BALLOON CATHETER WITH ENHANCED LOCATABILITYDecember 2021May 2025Abandon4141YesNo
17618686PEN NEEDLEDecember 2021May 2025Allow4111YesNo
17524610LACRIMAL DRUG DELIVERY DEVICENovember 2021February 2024Allow2711YesNo
17518062Medicament Delivery SystemNovember 2021July 2024Allow3321YesNo
17515470HYPODERMIC NEEDLE FOR INTRA-ARTERIAL/INTRAVENOUS LINE PLACEMENTOctober 2021June 2024Abandon3120NoNo
17514429Stabilized Pen InjectorOctober 2021May 2024Allow3100NoNo
17508459SYSTEMS, METHODS AND APPARATUS FOR GUIDING AND SUPPORTING CATHETERS AND METHODS OF MANUFACTUREOctober 2021May 2022Allow720YesNo
17506437SYRINGEOctober 2021May 2023Allow1800NoNo
17450849Data Collection Apparatus for Attachment to an Injection DeviceOctober 2021August 2023Allow2210YesNo
17500174SYRINGEOctober 2021December 2022Abandon1420YesNo
17488575PUMP INFUSION SYSTEMSeptember 2021November 2024Abandon3811NoNo
17487135METHOD FOR PROCESSING INFUSION DATA AND AN INFUSION PUMP SYSTEMSeptember 2021April 2024Allow3101YesNo
17466083SYRINGE WITH SYRINGE CLOSURESeptember 2021February 2025Allow4130YesNo
17431954INJECTION NEEDLEAugust 2021April 2025Allow4430NoNo
17401996VASCULATURE NAVIGATION SYSTEMS AND METHODSAugust 2021March 2023Allow1921NoNo
17398141VOLUME-BASED FLOW RATE COMPENSATION TECHNIQUE FOR INFUSION THERAPYAugust 2021December 2023Allow2800NoNo
17381737Syringe CarrierJuly 2021October 2022Allow1510YesNo
17368936DEVICE FOR THE DOSED ADMINISTRATION OF A FLUID PRODUCT, ADAPTED FOR THE REPLACEMENT OF A CONTAINERJuly 2021November 2023Allow2800YesNo
17419187DEVICE AND METHOD FOR DELIVERING AN INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USERJune 2021May 2024Allow3501YesNo
17363475METHOD OF USING AN INDWELLING CATHETER APPARATUS INCLUDING DISPOSABLE ANTI-MICROBIAL SLEEVEJune 2021March 2022Abandon910NoNo
17361912APPARATUSES AND METHODS FOR INJECTING MEDICAMENTSJune 2021March 2025Allow4521YesNo
17354559HEMOSTATIC VALVE, SHEATH, AND CATHETER SHEATH ASSEMBLYJune 2021November 2024Abandon4110NoNo
17416023CATHETER SYSTEMS AND RELATED METHODSJune 2021September 2024Abandon3910NoNo
17335684SYRINGEJune 2021October 2021Allow510YesNo
17335870Intraosseous Device and Data TransferJune 2021October 2024Abandon4121NoNo
17335822SYSTEM FOR ANCHORING MEDICAL DEVICESJune 2021April 2023Allow2300YesNo
17333133System, Method, and Apparatus for Estimating Liquid DeliveryMay 2021March 2024Allow3420YesNo
17298417SYSTEMS AND METHODS FOR CLOSED-LOOP CONTROL OF INSULIN-GLUCOSE DYNAMICSMay 2021March 2025Allow4511YesNo
17323377AUTO-INJECTION DEVICEMay 2021October 2023Allow2911YesNo
17321854Reducing Pulmonary Hypertension with Nitric Oxide MicrobubblesMay 2021October 2024Abandon4110NoNo
17314194GUIDEWIRE ASSEMBLYMay 2021May 2025Allow4931YesNo
17246643DEVICE AND METHOD FOR DELIVERING A FLOWABLE INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USERMay 2021April 2024Allow3601NoNo
17228319TUBE STRUCTUREApril 2021February 2024Abandon3410NoNo
17226692METHODS AND DEVICES FOR DELIVERING CANCER THERAPY TO A TARGET TISSUE SITE VIA A CORED TISSUE CAVITYApril 2021May 2025Abandon4911YesNo
17222436MEDICAL DEVICES FOR FLUID DELIVERYApril 2021June 2022Allow1420YesNo
17220634AUTO-INJECTION DEVICEApril 2021June 2023Allow2601YesNo
17281101CATAMENIAL FLUID REMOVALMarch 2021January 2025Allow4511YesNo
17210166AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAMEMarch 2021January 2025Allow4531YesNo
17186132APPARATUS AND METHODS FOR RESTORING TISSUEFebruary 2021November 2024Abandon4521NoNo
17183957Single Step Removal of Cannula Guard and Adhesive Liner in Medical DeviceFebruary 2021January 2024Abandon3411NoNo
17174981SYRINGEFebruary 2021April 2021Allow200YesNo
17168765SMART SMALL-BORE CONNECTOR DEVICEFebruary 2021March 2024Allow3720YesNo
17152546BILIARY ACCESS CATHETER SYSTEM AND METHODS FOR ACCESSING THE BILIARY TREEJanuary 2021April 2025Allow5140YesNo
17146532Delivery System and Mode of Operation ThereofJanuary 2021January 2024Abandon3610NoNo
17133149Data Collection Apparatus for Attachment to an Injection DeviceDecember 2020April 2024Allow3920YesNo
17127011FLUSHING STYLETDecember 2020April 2023Allow2800YesNo
17123968SPRING LOADED MEDICAL NEEDLE-FREE INJECTION SYSTEMDecember 2020July 2023Allow3160YesNo
17112925MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSDecember 2020December 2021Allow1230YesNo
17109575DRUG INJECTION DEVICEDecember 2020March 2023Allow2800YesNo
15734290MEDICAMENT DELIVERY DEVICEDecember 2020June 2024Allow4321YesNo
17059787ROLLING DIAPHRAGM SYRINGE WITH PISTON ENGAGEMENT PORTIONNovember 2020August 2024Abandon4511NoNo
17107241THREE-POSITION PLUNGERS, FILM COATED PLUNGERS AND RELATED SYRINGE ASSEMBLIESNovember 2020August 2023Allow3210NoNo
17107791CATHETER SYSTEMS AND DEVICES FOR ACUTE ISCHEMIC STROKE THROMBECTOMYNovember 2020May 2021Allow510YesNo
17102734DRUG PELLET INJECTOR NEEDLE AND METHOD TECHNICAL FIELDNovember 2020January 2023Allow2600NoNo
17057329SYRINGE-SHAPED SPRAYING DEVICENovember 2020January 2024Allow3810YesNo
16950635MEDICAMENT DELIVERY DEVICENovember 2020October 2023Allow3500YesNo
17055757CONNECTOR ASSEMBLIESNovember 2020June 2025Allow5531YesNo
17055097AUTOMATED SYSTEM FOR MONITORING A PATIENT'S BLOOD SUGARNovember 2020February 2024Allow3910YesNo
17095276MEDICAL DEVICES FOR ENDOSCOPICALLY DISPENSING AGENTS AND RELATED METHODS OF USENovember 2020January 2024Allow3811YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CARPENTER, WILLIAM R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
25
Examiner Affirmed
14
(56.0%)
Examiner Reversed
11
(44.0%)
Reversal Percentile
66.1%
Higher than average

What This Means

With a 44.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
49
Allowed After Appeal Filing
14
(28.6%)
Not Allowed After Appeal Filing
35
(71.4%)
Filing Benefit Percentile
40.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 28.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner CARPENTER, WILLIAM R - Prosecution Strategy Guide

Executive Summary

Examiner CARPENTER, WILLIAM R works in Art Unit 3783 and has examined 464 patent applications in our dataset. With an allowance rate of 65.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner CARPENTER, WILLIAM R's allowance rate of 65.5% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by CARPENTER, WILLIAM R receive 2.52 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by CARPENTER, WILLIAM R is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +57.3% benefit to allowance rate for applications examined by CARPENTER, WILLIAM R. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 21.2% of applications are subsequently allowed. This success rate is in the 16% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 17.6% of cases where such amendments are filed. This entry rate is in the 13% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 42.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 37% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 52.8% of appeals filed. This is in the 18% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 58.8% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.3% of allowed cases (in the 60% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.